SUMMARY COVID-19 is frequently associated with the onset of secondary infections,
especially in severe cases treated in the intensive care unit. While bacterial pathogens are …

Background The incidence of candidemia in our hospital has been stable over an 18‐year
period (1.3 episodes per 1000 admissions). Since March 2020, we have observed an …

Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …

The physiopathologic characteristics of COVID-19 (high levels of inflammatory cytokines and
T-cell reduction) promote fungal colonization and infection, which can go unnoticed because …

Severe COVID‐19 patients in ICU are at high risk for candidemia due to exposure to multiple
risk factors for candidemia. We aimed to compare the incidence of candidemia in ICU …

Background Patients with severe COVID-19 have emerged as a population at high risk of
invasive fungal infections (IFIs). However, to our knowledge, the prevalence of IFIs has not …

Viral infections can cause acute respiratory distress syndrome (ARDS), consequently
leading to susceptibility for secondary pulmonary infections. Over the past few weeks, a …

Infection with SARS-CoV-2 can lead to Coronavirus disease-2019 (COVID-19) and result in
severe acute respiratory distress syndrome (ARDS). Recent reports indicate an increased …

The epidemiology and mycology of invasive candidiasis in the ICU is well‐described in
certain types of critically ill patients but not in others. One population that has been scarcely …

The objectives of this study were to investigate the incidence of candidemia, as well as the
factors associated with Candida species distribution and fluconazole resistance, among …